Previous Article | Next Article ![]()
Journal of Bacteriology, August 2001, p. 4752-4760, Vol. 183, No. 16
Laboratory of Bacteriology, Rega Institute,
Katholieke Universiteit Leuven, 3000 Leuven,1
and Laboratory of Molecular Dynamics, Katholieke Universiteit
Leuven, 3001 Heverlee,4 Belgium; Centro
Nacional de Biotecnologia (CSIC), Campus de la Universidad Autonoma,
Cantoblanco, 28049 Madrid, Spain2; and
Department of Genetics, Groningen, Biomolecular Sciences
and Biotechnology Institute, University of Groningen, 9751 NN
Haren, The Netherlands3
Received 26 July 2000/Accepted 26 May 2001
Most bacterial membranes contain one or two type I signal
peptidases (SPases) for the removal of signal peptides from export proteins. For Streptomyces lividans, four different type
I SPases (denoted SipW, SipX, SipY, and SipZ) were previously
described. In this communication, we report the experimental
determination of the membrane topology of these SPases. A protease
protection assay of SPase tendamistat fusions confirmed the presence of
the N- as well as the C-terminal transmembrane anchor for SipY. SipX and SipZ have a predicted topology similar to that of
SipY. These three S. lividans SPases are currently the
only known prokaryotic-type type I SPases of gram-positive bacteria
with a C-terminal transmembrane anchor, thereby establishing a new
subclass of type I SPases. In contrast, S. lividans SipW
contains only the N-terminal transmembrane segment, similar to
most type I SPases of gram-positive bacteria. Functional analysis
showed that the C-terminal transmembrane anchor of SipY is important to
enhance the processing activity, both in vitro as well as in vivo.
Moreover, for the S. lividans SPases, a relation seems
to exist between the presence or absence of the C-terminal anchor and
the relative contributions to the total SPase processing activity in
the cell. SipY and SipZ, two SPases with a C-terminal anchor, were
shown to be of major importance to the cell. Accordingly, for SipW,
missing the C-terminal anchor, a minor role in preprotein processing
was found.
Most bacterial proteins exported by
the general secretion pathway (Sec pathway) are synthesized in the
cytoplasm as preproteins containing a signal peptide. The signal
peptide is required for targeting the precursor proteins to the
translocase (13, 35). Upon translocation, a type I signal
peptidase (SPase) (10, 11) removes the signal peptide.
This is required for the release of the mature protein from the plasma
membrane (9). Type I SPases are divided in two
subfamilies, prokaryotic (P)-type and eukaryotic endoplasmic reticulum
(ER)-type SPases (40). P-type SPases contain conserved serine and lysine residues which function as a catalytic serine/lysine dyad (41, 42). In ER-type SPases, the
lysine residue is replaced by a histidine residue.
Based on computer predictions for topological characterization,
SPases can be divided into four groups. The first group comprises SPases with one N-terminal anchor. This group contains most type I
SPases from gram-positive bacteria, the SPase from the
gram-negative species Bradyrhizobium japonicum (SipS
[28]), an SPase from the mitochondria (Imp1p
[2]), and finally, the catalytic subunits of the
ER-type SPases (26). SPases having two
N-terminal anchors are classified into the second group. They were
identified only in gram-negative bacteria. Haemophilus
influenzae SPase (16) is the only known member of
the third group, harboring SPases with three N-terminal
anchors. In the last group, SPases with both an N-terminal and a
C-terminal anchor are classified, e.g., Imp2p from the yeast
mitochondria (29), the SPase of the gram-negative bacterium Rhodobacter capsulatus (22), and SipW
of Bacillus subtilis (40), the only ER-type
SPase identified in bacteria.
Streptomyces bacteria are gram-positive soil bacteria
characterized by their mycelial growth and the production of vegetative exospores. Members of this genus produce over 60% of the naturally occurring antibiotics, as well as several industrially important hydrolytic enzymes. Thanks to its excellent secretion capacity, Streptomyces, and Streptomyces lividans in
particular, has been intensively investigated for the secretory
production of heterologous proteins (1, 3, 17, 25, 45).
Recently, four different type I SPases in S. lividans
were identified (31, 32, 37). Transcriptional analysis
revealed that three genes (sipW, sipX, sipY) constitute an
operon, while the fourth (sipZ) is the first gene of another
operon together with three unrelated genes (32). Only
B. subtilis was shown to have more (five chromosome-encoded and two plasmid-encoded) type I SPases (40).
In this report, the membrane topology of the S. lividans
SPases was experimentally analyzed. Therefore, the monomeric
tendamistat protein (TM) (47) was used as a novel
reporter protein in protease protection experiments. Interestingly, TM
fusion analyses confirmed the computer-based topology with both an N-
and C-terminal transmembrane anchor for SipY, a unique feature for
P-type type I SPases of gram-positive bacteria. Functional analysis
demonstrated the importance of this domain in the processing
efficiency. In addition, SipY and SipZ, both containing the C-terminal
anchor, were found to be determining factors in the total processing
capacity of the cell. The membrane topology of S. lividans
SipW was experimentally proven to be similar to the predicted membrane
topology of most type I SPases of gram-positive bacteria.
Bacterial strains and growth conditions
For
cloning purposes, Escherichia coli TG1 cells were used
and grown at 37°C (300 rpm) in Luria broth (LB) (27) in
the presence of ampicillin (50 µg/ml). For purification purposes,
sip genes were expressed in E. coli
BL21(DE3)pLysS (38) grown in LB in the presence of
chloramphenicol (25 µg/ml) and ampicillin (50 µg/ml). For leader
peptidase (Lep) complementation assays, E. coli IT89
cells (20), which were grown in LB supplemented with 50 µg of ampicillin/ml and 5 µg of tetracycline/ml, were used. For
solid media, 15 g of agar was added per liter.
0021-9193/01/$04.00+0 DOI: 10.1128/JB.183.16.4752-4760.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Membrane Topology of the Streptomyces lividans
Type I Signal Peptidases

![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
DNA techniques
All DNA manipulations used in
this work were performed by standard procedures (36).
Restriction endonucleases and other DNA-modifying enzymes were
purchased from Roche Diagnostics (Mannheim, Germany), Eurogentec
(Seraing, Belgium), and Life Technologies (Gaithersburg, Md.).
Oligonucleotides (Table 1) were obtained from Amersham Pharmacia Biotech (Rainham, United Kingdom). All plasmids
used are listed in Table 2. PCR was
carried out with Pfu polymerase (Stratagene Europe,
Amsterdam, The Netherlands). DNA sequence analysis was performed
according to the dideoxy chain termination method with a Thermo
sequenase fluorescent labeled primer cycle sequencing kit with
7-deaza-dGTP (Amersham Pharmacia Biotech). Random primed DNA labeling
with digoxigenin-11-dUTP (DIG) was performed as previously described
(18).
|
|
Colony hybridization S. lividans colonies were grown on nylon filters (Hybond N+; Amersham Pharmacia Biotech) placed on agar plates containing kanamycin (50 µg/ml) at 27°C for 2 days. The filters (colony side up) were first transferred onto five stacked sheets of Whatman 3MM filter paper soaked for 15 min in a solution containing 4 mg of lysozyme/ml in Tris-EDTA buffer (pH 7.8), then transferred onto five sheets of paper soaked in 1.5 M NaCl-0.5 M NaOH for 20 min, and finally transferred onto five sheets of paper soaked in neutralization solution (0.5 M Tris-HCl [pH 7.2], 1.5 M NaCl, 1 mM EDTA) for 5 min. This step was repeated three times. After washing with a 2× SSC solution (0.3 M NaCl, 0.03 M Na3citrate), the filters were dried and the DNA was cross-linked to the membrane by UV radiation. Subsequently, the fixed DNA was hybridized with a tendamistat fragment labeled with DIG according to a method described by Engler-Blum et al. (14). The chemiluminescent detection procedure was performed as described by Hoeltke et al. (18).
Construction of expression plasmids
To
express the SPase-TM fusions in S. lividans,
expression vectors were constructed by inserting the coding sequence
for the desired fusion protein in the pIJ6021 plasmid downstream from the tipA promoter. Using pSN40 (Table 2) as a template,
DNA fragments coding for the SPases or N-terminal fragments thereof
were generated by PCR. Primers were designed for cloning these
fragments upstream of the tendamistat reporter gene in pTM (Fig.
1) in such a way that a fusion protein
was obtained with tendamistat. The appropriate PCR products were
treated with NdeI-SmaI for SipY86, with
NdeI-NaeI for SipY304, with
NdeI-StuI for SipY336, or with
NdeI-NsiI (blunted with T4 DNA
polymerase) for SipW259 and were cloned into the
NdeI-HincII sites of pTM,
resulting in pY86TM, pY304TM, pY336TM, and pW259TM, respectively.
Finally, the NdeI-EcoRI fragments of
pY86TM, pY304TM, pY336TM, and pW259TM were cloned into the
corresponding sites of the S. lividans pIJ6021
plasmid, resulting in pIJY86TM, pIJY304TM, pIJY336TM, and pIJW259TM,
respectively, in such a way that the fusion proteins were under the
control of the thiostrepton inducible promoter tipA
(39).
|
Expression of SPase-TM fusion proteins in S. lividans. Five milliliters of liquid phage medium was inoculated with 4 × 106 S. lividans spores. The mycelium from this preculture, grown for 3 days at 27°C, was fragmented in a glass homogenizer, and 1 ml of homogenate was used to inoculate 50 ml of NB medium. After 12 h of growth, the expression of the fusion proteins was induced by the addition of 5 µg of thiostrepton (Calbiochem, San Diego, Calif.)/ml (39) and incubation was continued for 24 h. A 1-ml sample was centrifuged (5 min, 2,000 × g) to harvest the mycelium. The cell pellet was subsequently resuspended in 1 ml of ice-cold 50 mM Tris-HCl, pH 7.5, and cell lysates were prepared by sonication on ice (three times for 30 s each time; 100 W Ultrasonic disintegrator [Measuring & Scientific Equipment, Ltd., London, United Kingdom]).
Expression and purification of SipY304 and
SipY336
A 500-ml culture of E.
coli BL21(DE3)pLysS cells harboring pEX20 or pEX23 was grown
until it reached an optical density at 600 nm (OD600) of
0.6. Expression of the Sip proteins was then induced by the addition of
IPTG (isopropyl-
-D-thiogalactopyranoside) to a final
concentration of 1 mM. Growth of the culture was continued for 3 h, after which the cells were harvested by centrifugation (10 min,
5,000 × g). The collected cells were resuspended
in 25 ml of lysis buffer (50 mM Tris-HCl, pH 8, 20% sucrose, 10%
glycerol). Cells were lysed by passing them three times through a
French pressure cell at 15,000 lb/in2, and the cell debris
was removed by centrifugation (20 min, 12,000 × g). To isolate the membrane fraction, the cell lysate
was centrifuged for 2 h at 100,000 × g.
Subsequently, the pellet was resuspended in 5 ml of solubilization
buffer (50 mM NaH2PO4, pH 8, 300 mM NaCl, 10%
glycerol, 0.5% Triton X-100). After 1 h on ice, the sample was
recentrifuged (1 h, 100,000 × g) and the extracted membrane proteins were loaded onto a 5-ml Ni-nitrilotriacetic acid
column equilibrated with solubilization buffer. The column was washed
with 5 ml of solubilization buffer plus 10 and 20 mM imidazol,
successively. Fractions of 1 ml were collected and analyzed for purity
on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gels.
Isolation of S. lividans membranes. After homogenization of the mycelium of a 5-ml S. lividans preculture in phage medium, 1 ml was used to inoculate 50 ml of NB medium which was incubated for an additional 24 h. The mycelium was harvested by centrifugation (5 min, 1,000 × g), and the cells were lysed in a French pressure cell (three times, 15,000 lb/in2). After removal of the cell debris by centrifugation (20 min, 12,000 × g), the cell lysate was centrifuged for 2 h at 100,000 × g. The cell pellet was resuspended in 50 mM Tris-HCl (pH 8)-5 mM MgSO4 containing complete Mini EDTA-free protease inhibitor cocktail tablets (Roche Diagnostics) and normalized for protein content (10 mg/ml) (Bio-Rad protein assay).
Preparation of anti-tendamistat and anti-SipY antibodies. Purified tendamistat (250 µg in 500 µl), kindly provided by J. W. Engels, was mixed with 500 µl of complete Freund's adjuvant and intramuscularly injected (two 1-ml injections at a 3-week interval) in a Hollander rabbit. Two weeks after the last injection, blood was sampled and the serum was collected by centrifugation (5 min, 150 × g). Because of the high background observed, the anti-tendamistat antibodies were further purified on a 1-ml HiTrap N-hydroxysuccinimide-activated column with the antigen tendamistat covalently bound to the matrix by using the ÄKTA prime purification system (Amersham Pharmacia Biotech). Coupling of tendamistat to the matrix was performed according to the manufacturer's recommendations. After dialysis of the serum against binding buffer (75 mM Tris-HCl, pH 8; overnight at 4°C), the soluble fraction was transferred to the prepared column. Following this, the column was washed with 10 column volumes of binding buffer. Bound anti-tendamistat antibodies were eluted with a solution of 100 mM glycine-HCl-500 mM NaCl (pH 2.7) and collected in 1-ml fractions. Elution fractions were neutralized with 1 N NaOH and analyzed by SDS-PAGE. Specific anti-SipY antibodies were prepared analogously to the described protocol.
Western blotting and protein detection Proteins were separated by SDS-PAGE as described by Laemmli (24). Transfer of proteins onto a nitrocellulose Porablot membrane (Macherey Nagel, Düren, Germany) was performed with the aid of a Transblot semidry transfer cell (Bio-Rad) according to the manufacturer's recommendations. The fusion proteins were detected colorimetrically with polyclonal rabbit anti-tendamistat antiserum and anti-rabbit immunoglobulin G conjugated to alkaline phosphatase (AP).
Protease protection assay of SPase-TM fusion proteins To 15 µl of a protoplast suspension (OD600 = 1.0), 2 µl of water or 2 µl of 10% Triton X-100 was added, followed by 3 µl of a solution of trypsin (10 mg/ml in 50 mM Tris-HCl, pH 8.3). After 15 to 30 min of incubation at room temperature, 4 µl of 6× SDS-loading buffer (0.35 M Tris-HCl, pH 6.8, 0.35 M SDS, 30% [vol/vol] glycerol, 0.6 M dithiothreitol, 0.175 mM bromophenol blue) was added and the samples were placed at 100°C for 2 min. After separation by SDS-PAGE, the proteins were transferred to a nitrocellulose membrane and detected following Western blotting as described above.
In vitro activity assay. Quantitative analysis of the in vitro activities of purified SipY304 and SipY336 was performed using an assay previously described for Lep (49). An internally quenched fluorescent peptide derived from the E. coli maltose binding protein signal peptide (Californian Peptide Research) was used as a substrate. After a 3-min preincubation period of the peptide (final concentration, 20 µM) at 42°C in assay buffer (50 mM Tris-HCl, pH 9, 1% Triton X-100), the reaction was initiated by the addition of the SPase (final concentration, 2.5 µM). Cleavage by the SPase leads to the removal of the quenching group, which in turn results in an increase of fluorescence. The fluorescent emission signal at 400 nm was measured as a function of time on a Spex 1860 Double Spectrophotometer (SPEX Instruments S.A., Longjumeau, France) using an excitation wavelength of 340 nm. The data shown are the averages of three independent measurements.
The reaction velocity was calculated by converting the units of the observed velocities from fluorescence units per second to nanomoles per second by using the following equation: vnM/s = vFI/s/[(FIt=
FIt =
0)/S0], where vnM/s is the reaction velocity (in
nanomolar per second), vFI/s is the
reaction velocity (in fluorescence units per second),
FIt=
is the fluorescence intensity at
the end point reading, FIt=0 is the
fluorescence intensity at zero time, and
S0 is the initial substrate nanomolar
concentration. Because the reactions were too slow to enable monitoring
the reaction to completion, the end point was determined by adding 20 µl of an alkaline protease solution (Promega, Madison, Wis.) in order
to completely hydrolyze the substrate.
The processing rates of membrane fractions isolated from S. lividans wild-type and SPase knock-out strains were measured
according to an identical procedure, but at 27°C. As a negative
control, wild-type S. lividans membranes, which were
preincubated for 5 min with 0.2 mM penem SB-214357 (an SPase
inhibitor) (4, 34), were added. All membranes were tested
at a final protein concentration of 0.1 mg/ml.
| |
RESULTS |
|---|
|
|
|---|
Computer-aided hydrophobicity analysis
The
positions of the putative membrane-spanning segments in the amino acid
sequences of the four SPases were identified by the
TopPred 2 program (http://www.biokemi.su.se/~server/toppred2 /toppredServer.cgi)
(8, 48), a program which generates hydrophobicity profiles. S. lividans SipY was predicted to have two
hydrophobic domains which could act as possible transmembrane anchors,
amino acids (aa) 87 to 100 [A(nchor)I] and aa 305 to 325 [A(nchor)II]. SipX and SipZ have a predicted topology similar to that
of SipY. For SipW, only one hydrophobic region (aa 48 to 63) was
predicted to be a transmembrane segment (Fig.
2).
|
Expression of fusion proteins in S. lividans and
determination of membrane topology by using a trypsin protection
assay
The predicted topology was investigated
experimentally by constructing a series of fusion proteins with SipY
and SipW, the former predicted to have one C-terminal anchor and the
latter to have none (Fig. 2). As a reporter protein, tendamistat (the
-amylase inhibitor of Streptomyces tendae)
(47) was chosen. All fusions were constructed at the C
terminus of a hydrophilic region to avoid the disruption of the two
known classes of topogenic signals (membrane-spanning segments and
short hydrophilic regions with a net positive charge) (5).
|
Functional analysis of the presence of the C-terminal anchor The importance of the C-terminal anchor in the SPase processing activity was studied in vitro and in vivo by comparing the activity of a SipY derivative lacking the C-terminal anchor with the wild-type SipY.
The in vivo activity of the wild-type SipY and the C-truncated SipY derivative was assessed by their capacity to complement Lep. Therefore, E. coli IT89, which possesses a temperature-sensitive defect in Lep activity, was transformed with the plasmids pEXSipY304 and pEXSipY336. At nonpermissive temperature, the growth curves were monitored (Fig. 4A). Both SipY336 and the C-truncated SipY304 mutant were able to functionally replace the E. coli Lep. Deletion of the C-transmembrane anchor was, as a consequence, not inhibitory for the SPase activity by itself. However, we observed a slower growth rate for E. coli IT89 (pEXSipY304) cells compared to that of the cells containing pEXSipY336. It was considered that the difference could be due to a lower stability or activity of the mutant protein relative to that of the authentic SipY. Figure 4B shows the result of the immunoblot analysis of total protein extract from E. coli IT89 cells expressing SipY304 or SipY336, grown at 42°C until reaching an OD600 of 0.4, probed with rabbit polyclonal antiserum to SipY. Similar immunodetectable concentrations of both enzymes were present, thereby demonstrating the stable accumulation of the SipY304 mutant. As a consequence, the lower growth rate could not be attributed to partial degradation or a decrease in the concentration of the C-truncated SipY derivative relative to that of wild-type SipY.
|
|
, SipY
,
SipZ
), one double mutant
(SipW
X
), and one triple
mutant
(SipW
X
Y
)
were obtained. All these S. lividans SPase knock-out
strains were viable, indicating that none of the SPases is
essential by itself for cell viability, similar to the five B. subtilis SPases, and that the SPases can at least partly
complement each other. A mutant strain lacking both SipY and SipZ could
not be obtained so far. This might indicate that such a double
knock-out mutant would not be viable. In a next step, the in vitro
SPase activity of membrane fractions isolated from these
strains was compared with that of membranes isolated from the wild-type
strain. In this test, the peptide substrate described above was used.
The calculated processing rates are listed in Table
3. As a blank, wild-type
S. lividans membranes incubated with penem SB-214357 were
used. This made it possible to detect background processing from
proteases which were not inhibited. In practice, no significant processing rates were detected, showing that the assay was specific for
SPase activity. The highest decrease in processing activity was
observed for S. lividans membrane fractions lacking
SipW
X
Y
.
Furthermore, only deletion of SipY or SipZ led to a significant reduction in activity. Deleting SipX or SipX plus SipW did not significantly affect the processing activity of the membranes. In
first instance, it seems that in S. lividans cells,
SipZ is necessary but not sufficient to obtain a high
processing activity. In contrast, compared to the
SipW
X
Y
membranes, in which only SipZ is active, the addition of SipY alone (in
the SipW
X
membranes)
was sufficient to exhibit almost wild-type processing activities. This
indicates that both SipY and SipZ are important contributors to the
SPase processing capacity of the cell. Interestingly, almost no
negative influence was observed on the processing activity of the
membranes only when SipY and SipZ were both active.
|
| |
DISCUSSION |
|---|
|
|
|---|
The most important result of this work is the experimental confirmation of the C-terminal transmembrane anchor of SipY, which is presently unique to P-type type I SPases of gram-positive bacteria. According to the TopPred 2 program, S. lividans SipX and SipZ have a similar membrane topology and belong to the same exceptional group of P-type SPases. Both N- and C-terminal anchors are also present in the SPase of gram-negative R. capsulatus (22), Imp2p of Saccharomyces cerevisiae mitochondria (29), and two ER-type SPases: SipW of B. subtilis (40) and SCP21 of Archaeoglobus fulgidus (21).
In contrast, S. lividans SipW was found not to have a C-terminal membrane anchor. It possesses only one N-terminally located transmembrane anchor, similar to most SPases of gram-positive bacteria described so far. Because all known SPases from gram-positive bacteria have a single N-terminal transmembrane segment and because its presence was already confirmed for one S. lividans SPase (SipY), no additional TM fusion was constructed for the SipW part N-terminal of the transmembrane segment.
In this experimental approach, two different reporter proteins were used, the small monomeric Streptomyces TM protein and the large multimeric E. coli AP protein. The latter is (together with LacZ) one of the most frequently used reporter proteins for topological studies. In our experiments, two major problems with the constructed SPase-AP fusions were encountered: (i) instability of the cytoplasmically located SPase-AP fusions proteins in E. coli (12, 43) and (ii) no expression of the SPase-AP fusions in S. lividans or no detectable production for unknown reasons. Thus, in those cases where the commonly used reporter proteins (which are all large, multimeric complex proteins) fail, the small monomeric polypeptide tendamistat could be a valuable alternative as a reporter protein to determine subcellular localization.
Little is known so far about the function of the SPase transmembrane segments. The most frequently allocated functions, based on studies for N-terminal transmembrane anchors, are the insertion of the SPase in the membrane and the prevention of intermolecular self-cleavage (46). Very recently, Carlos et al. (7) revealed that the N-terminal transmembrane anchors of E. coli Lep and the B. subtilis SipS are not important for determining the in vitro cleavage fidelity, because soluble derivatives of these enzymes retain the same substrate specificity.
Here, we showed both in vitro as well as in vivo that the C-terminal anchor of SipY is important to enhance the processing activity. We favor the idea that the C-terminal anchor, in addition to its role to position the SPase in the lipid bilayer (in vivo) or in detergent micelles (in vitro), plays a role in the overall structure of the SPase, thereby positioning the catalytic residues relative to each other. Consequently, removal of this anchor could lead to a less efficient membrane insertion and a change in conformation, resulting in a weaker interaction between the catalytically important residues, which in turn can cause the observed decrease in processing efficiency.
These topological analyses revealed that three of the four S. lividans SPases have a C-terminal anchor. In contrast, in
B. subtilis, which contains five chromosomally encoded
SPases, only SipW, which has a minor role in pre-protein
processing, contains a C-terminal anchor. Considering this, the
question was raised of whether a relationship in S. lividans
exists between the presence of the C-terminal anchor and the relative
importance of that respective SPase for the total processing
capacity of the cell. This was analyzed by comparing the SPase
activity of membranes isolated from several S. lividans
SPase knock-out mutants, i.e., S. lividans SipX
, SipY
,
SipZ
,
SipW
X
, and a triple
mutant,
SipW
X
Y
.
The quantitative in vitro activity measurements of isolated membranes
of these strains showed the important contribution of SipY and SipZ to
the total processing capacity of the cell. These findings, together
with the fact that, up to now, it was not possible to isolate an
S. lividans strain lacking both SipY and SipZ, strongly suggest that SipY and SipZ (SPases containing a C-terminal anchor) are of major importance for the cell. Accordingly, SipW, the only SPase without a C-terminal anchor, seems to be of minor importance.
Finally, a question was raised on whether a link exists between the unexpected finding that the majority of SPases found in S. lividans have two anchoring domains and the characteristics of the substrates processed by these SPases. When the processing activities of SPases from gram-positive bacteria were tested on known substrates of the E. coli Lep, none of them could process these substrates as efficiently as Lep (33). These findings indicate that prominent differences may exist in substrate specificity between the SPases of gram-negative and gram-positive bacteria. Moreover, even within the latter group, remarkable differences do appear, i.e., when we look more closely at signal peptide characteristics of proteins secreted by Streptomyces, its signal peptides are significantly different from those of all other bacteria, both in the total lengths of the N and C regions and in the positive charge of the N region, as well as in the number of hydrophobic residues present in the H region. Conceivably, the presence of the C-terminal anchor reflects an evolutionary adaptation of the Streptomyces SPases to this particular phenomenon.
In addition, the observed differences in membrane topology together with the existing differences between the conserved regions containing the catalytically important amino acids may not only affect the enzymatic activity itself but can also influence the substrate specificity of the different Streptomyces SPases. Interestingly, the distance in the primary structure between boxes C and D is about 30 amino acids longer in SipY (and SipX) than in SipW (and SipZ). As a consequence, the distance between the catalytic serine and lysine is about 30 amino acids longer than in all other SPases described so far. Differences in substrate specificity between the multiple SPases of B. subtilis have already been reported (6). Because processing by the SPases was identified as a bottleneck for the secretion of certain proteins in S. lividans (V. Parro, unpublished data) and B. subtilis (40), this observation could be promising for the engineering of the secretion machinery for improved secretion of both native and heterologous proteins by S. lividans.
| |
ACKNOWLEDGMENTS |
|---|
We thank J. W. Engels (J. W. Goethe University, Frankfurt, Germany) for providing the purified tendamistat, GlaxoSmithKline for the gift of penem SB-214357, and J. M. van Dijl (University of Groningen, Groningen, The Netherlands) for stimulating discussions.
This work is supported by a grant (BIO4-CT98-0051) from the European Commission and FWO (G.0271.98). N.G. and K.S. are research fellows of IWT.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Laboratory of Bacteriology, Rega Instituut, Katholieke Universiteit Leuven, Minderbroedersstraat 10, 3000 Leuven, Belgium. Phone: 32 16 33 73 71. Fax: 32 16 33 73 40. E-mail: Jozef.anne{at}rega.kuleuven.ac.be.
Present address: Centro de Astrobiologia (CSIC-INTA),
Torrejón de Ardoz, 28850 Madrid, Spain.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Anné, J., and L. Van Mellaert. 1993. Streptomyces lividans as host for heterologous protein production. FEMS Microbiol. Lett. 114:121-128[CrossRef][Medline]. |
| 2. | Behrens, M., G. Michaelis, and E. Pratje. 1991. Mitochondrial inner membrane protease 1 of Saccharomyces cerevisiae shows sequence similarity to the Escherichia coli leader peptidase. Mol. Gen. Genet. 228:167-176[CrossRef][Medline]. |
| 3. | Binnie, C., J. D. Cossar, and D. I. Stewart. 1997. Heterologous biopharmaceutical protein expression in Streptomyces. Trends Biotechnol. 15:315-320[CrossRef][Medline]. |
| 4. | Black, M. T., and G. Bruton. 1998. Inhibitors of bacterial signal peptidases. Curr. Pharm. Design. 4:133-154[Medline]. |
| 5. |
Boyd, D.,
B. Traxler, and J. Beckwith.
1993.
Analysis of the topology of a membrane protein by using a minimum number of alkaline phosphatase fusions.
J. Bacteriol.
175:553-556 |
| 6. | Bron, S., A. Bolhuis, H. Tjalsma, S. Holsappel, G. Venema, and J. M. van Dijl. 1998. Protein secretion and possible roles for multiple signal peptidases for precursor processing in bacilli. J. Biotechnol. 64:3-13[CrossRef][Medline]. |
| 7. |
Carlos, J. L.,
M. Paetzel,
G. Brubaker,
A. Karla,
C. M. Ashwell,
M. O. Lively,
G. Cao,
P. Bullinger, and R. E. Dalbey.
2000.
The role of the membrane-spanning domain of type I signal peptidases in substrate cleavage site selection.
J. Biol. Chem.
275:38813-38822 |
| 8. |
Claros, M. G., and G. von Heijne.
1994.
TopPred 2: an improved software for membrane protein structure prediction.
Comput. Appl. Biosci.
10:685-686 |
| 9. | Dalbey, R., and W. Wickner. 1985. Leader peptidase catalyses the release of exported proteins from the outer surface of the E. coli outer membrane. J. Biol. Chem. 230:15925-15931. |
| 10. | Dalbey, R., and G. von Heijne. 1992. Signal peptidases in prokaryotes and eukaryotes: a new protease family. Trends Biochem. Sci. 17:474-478[CrossRef][Medline]. |
| 11. | Dalbey, R., M. O. Lively, S. Bron, and J. M. van Dijl. 1997. The chemistry and enzymology of the type I signal peptidases. Protein Sci. 6:1129-1138[Abstract]. |
| 12. | Danielsen, S., D. Boyd, and J. Neuhard. 1995. Membrane topology analysis of the Escherichia coli cytosine permease. Microbiology 141:2905-2913[Abstract]. |
| 13. | Driessen, A. J. M. 1994. How proteins cross the bacterial cytoplasmic membrane. J. Membr. Biol. 142:145-159[Medline]. |
| 14. | Engler-Blum, G., M. Meier, J. Frank, and G. A. Müller. 1993. Reduction of background problems in nonradioactive Northern and Southern blots analyses enables higher sensitivity than 35P-based hybridisations. Anal. Biochem. 210:235-244[CrossRef][Medline]. |
| 15. |
Fass, S. H., and J. W. Engels.
1996.
Influence of specific signal peptide mutations on the expression and secretion of the -amylase inhibitor tendamistat in Streptomyces lividans.
J. Biol. Chem.
271:15244-15252 |
| 16. |
Fleischmann, R. D.,
M. D. Adams,
O. White,
R. A. Clayton, et al.
1995.
Whole-genome random sequencing and assembly of Haemophilus influenzae Rd.
Science
269:496-512 |
| 17. | Gilbert, M., R. Morosoli, F. Shareck, and D. Kluepfel. 1995. Production and secretion of proteins by Streptomycetes. Crit. Rev. Biotechnol. 15:13-39[Medline]. |
| 18. | Hoeltke, H. J., S. Schneider, I. Ettl, R. Binsack, I. Obermaier, M. Seller, and G. Sagner. 1995. Rapid, highly sensitive detection of digoxigenin-labeled nucleic acids by improved chemiluminescent alkaline phosphatase substrates. Biochemica 1:17-20. |
| 19. | Hopwood, D. A., M. J. Bibb, K. Chater, T. Kieser, C. J. Bruton, J. M. Ward, H. M. Kieser, D. J. Lydiate, C. P. Smith, and H. Schrempf. 1985. Genetic manipulation of Streptomyces: a laboratory manual. John Innes Foundation, Norwich, United Kingdom. |
| 20. |
Inada, T.,
D. L. Court,
K. Ito, and Y. Nakamura.
1989.
Conditionally lethal amber mutations in the leader peptidase gene of Escherichia coli.
J. Bacteriol.
171:585-587 |
| 21. | Klenk, H. P., R. A. Clayton, J.-F. Tomb, O. White, et al. 1997. The complete genome sequence of the hyperthermophilic, sulphate reducing archaeon Archaeoglobus fulgidus. Nature 390:364-370[CrossRef][Medline]. |
| 22. | Klug, G., A. Jaeger, C. Heck, and R. Rauhut. 1997. Identification, sequence analysis and expression of the lepB gene for a leader peptidase gene in Rhodobacter capsulatus. Mol. Gen. Genet. 253:666-673[CrossRef][Medline]. |
| 23. | Korn, F., B. Weingärtner, and H. J. Kutzner. 1978. A study of twenty actinophages: morphology, serological relationship and host range. In E. Freechsen, I. Tarnak, and J. H. Thumin (ed.), Genetics of the Actinomycetales. Gustav Fisher Verlag, New York, N.Y. |
| 24. | Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685[CrossRef][Medline]. |
| 25. | Lammertyn, E., L. Van Mellaert, S. Schacht, C. Dillen, E. Sablon, A. Van Broekhoven, and J. Anné. 1997. Evaluation of a novel subtilisin inhibitor gene and mutant derivatives for the expression and secretion of mouse tumor necrosis factor alpha by Streptomyces lividans. Appl. Environ. Microbiol. 63:1808-1813[Abstract]. |
| 26. | Lively, M. O., and G. S. Shelness. 1994. Eukaryotic microsomal signal peptidase. In G. von Heijne (ed.), Signal peptidase. R.G. Landes Company, Austin, Tex. |
| 27. | Miller, J. H. 1972. Experiments in molecular genetics. Cold Spring Laboratory Press, Cold Spring Harbor, N.Y. |
| 28. | Müller, P., K. Ahrens, and A. Klauche. 1995. A tnphoA insertion within the Bradyrhizobium japonicum sipS gene, homologous to prokaryotic signal peptidases results in extensive exchanges in the expression of the PMB-specific nodulins of infected soybean (Glycin max) cells. Mol. Microbiol. 18:831-840[CrossRef][Medline]. |
| 29. |
Nunnari, J.,
T. D. Fox, and P. Walter.
1993.
A mitochondrial protease with two catalytical subunits of non-overlapping specificities.
Science
262:1997-2004 |
| 30. |
Parro, V.,
D. A. Hopwood,
F. Malpartida, and R. P. Mellado.
1991.
Transcription of genes involved in the earliest steps of actinorhodin biosynthesis in Streptomyces coelicolor.
Nucleic Acids Res.
19:2623-2627 |
| 31. | Parro, V., and R. P. Mellado. 1998. A new signal peptidase gene from Streptomyces lividans TK21. DNA Sequence 9:71-77[Medline]. |
| 32. |
Parro, V.,
S. Schacht,
J. Anné, and R. P. Mellado.
1999.
Four genes encoding different type I signal peptidases are organised in a cluster in Streptomyces lividans TK21.
Microbiology
145:2255-2263 |
| 33. |
Peng, S.-B.,
L. Wang, L.,
J. Moomaw,
R. B. Peery,
P.-M. Sun,
R. B. Johnson,
J. Lu,
P. Treadway,
P. L. Skatrud, and Q. M. Wang.
2001.
Biochemical characterization of signal peptidase I from gram-positive Streptococcus pneumoniae.
J. Bacteriol.
183:621-627 |
| 34. | Perry, C. R., M. J. Ashby, and S. A. Elsmere. 1995. Penems as research tools to investigate the activity of E. coli leader peptidase. Biochem. Soc. Trans. 548S:23. |
| 35. | Pugsley, A. 1993. The complete general secretory pathway in Gram-negative bacteria. Microbiol. Rev. 37:50-108. |
| 36. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 37. | Schacht, S., L. Van Mellaert, E. Lammertyn, H. Tjalsma, J. M. van Dijl, S. Bron, and J. Anné. 1998. The sip(sli) gene of Streptomyces lividans TK24 specifies an unusual signal peptidase with a putative C-terminal anchor. DNA Sequence 9:79-88[Medline]. |
| 38. | Studier, F. W., and B. A. Moffat. 1986. Use of T7 RNA polymerase to direct selective high-level expression of cloned genes. J. Mol. Biol. 189:113-130[CrossRef][Medline]. |
| 39. | Takano, E., J. White, C. J. Thompson, and M. J. Bibb. 1995. Construction of thiostrepton-inducible high-copy-number expression vectors for use in Streptomyces spp. Gene 166:133-137[CrossRef][Medline]. |
| 40. |
Tjalsma, H.,
A. Bolhuis,
M. L. van Roosmalen,
T. Wiegert,
W. Schumann,
C. P. Broekhuizen,
W. J. Quax,
G. Venema,
S. Bron, and J. M. van Dijl.
1998.
Functional analysis of the secretory precursor processing machinery of Bacillus subtilis: identification of a eubacterial homologue of archaeal and eukaryotic signal peptidases.
Genes Dev.
12:2318-2331 |
| 41. |
Tschantz, W. R.,
M. Sung,
V. M. Delgado-Partin, and R. Dalbey.
1993.
A serine and a lysine residue implicated in the catalytic mechanism of the Escherichia coli leader peptidase.
J. Biol. Chem.
268:27349-27354 |
| 42. |
van Dijl, J. M.,
A. de Jong,
G. Venema, and S. Bron.
1995.
Identification of the potential active site of the signal peptidase SipS of Bacillus subtilis.
J. Biol. Chem.
270:3611-3618 |
| 43. |
van Geest, M., and J. S. Lolkema.
2000.
Membrane topology and insertion of membrane proteins: search for topogenic signals.
Microbiol. Mol. Biol. Rev.
64:13-33 |
| 44. | Van Mellaert, L., C. Dillen, P. Proost, E. Sablon, R. DeLeys, H. Van Broekhoven, H. Heremans, J. Van Damme, H. Eyssen, and J. Anné. 1994. Efficient secretion of biologically active mouse tumor necrosis factor alpha by Streptomyces lividans. Gene 150:153-158[CrossRef][Medline]. |
| 45. | Van Mellaert, L., and J. Anné. 1999. Protein secretion in Gram-positive bacteria with a high GC-content. Recent Res. Dev. Microbiol. 3:324-340. |
| 46. |
van Roosmalen, M. L.,
J. D. H. Jongbloed,
A. Kuipers,
G. Venema,
S. Bron, and J. M. Van Dijl.
2000.
A truncated soluble Bacillus signal peptidase produced in Escherichia coli is subject to self-cleavage at its active site.
J. Bacteriol.
182:5765-5770 |
| 47. |
Vértesy, L.,
V. Oeding,
R. Bender,
K. Zepf, and G. Nesemann.
1984.
Tendamistat, a tight -amylase inhibitor.
Eur. J. Biochem.
141:505-512[Medline].
|
| 48. | von Heijne, G. 1992. Membrane protein structure prediction: hydrophobicity analysis and the positive-inside rule. J. Mol. Biol. 252:487-494. |
| 49. | Zhong, W., and S. J. Benkovic. 1998. Development of an internally quenched fluorescent substrate for Escherichia coli leader peptidase. Anal. Biochem. 255:66-73[CrossRef][Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Appl. Environ. Microbiol. | Infect. Immun. | Eukaryot. Cell |
|---|---|---|
| Mol. Cell. Biol. | J. Virol. | Microbiol. Mol. Biol. Rev. |
| ALL ASM JOURNALS |